RNF220
protein-codingring finger protein 220, the group of MicroRNA protein coding host genes|Ring finger proteins
Gene summary
Enables beta-catenin binding activity and ubiquitin protein ligase activity. Involved in positive regulation of canonical Wnt signaling pathway and protein polyubiquitination. Acts upstream of or within positive regulation of transcription by RNA polymerase II and protein monoubiquitination. Located in nuclear lamina and nucleoplasm. Part of protein-containing complex. Implicated in hypomyelinating leukodystrophy 23. [provided by Alliance of Genome Resources, Jun 2026]
- C1orf164
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~246.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030514
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030514
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Neurologic
Intervention: Cardiovascular
Rationale: Among other features, the condition may include cardiomyopathy, and awareness may allow early management of this issue
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RNF220 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018150.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 8 | |||
| missense | 2 | 64 | 66 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 6 | 6 | ||||
| Total | 2 | 0 | 71 | 7 | 0 | 80 |
Highest pathogenic variant AF is 0.000006207155
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060620.2 | 14 | MANE Select | |
| Ensembl | ENSP00000354872.2 | 14 | MANE Select | |
| RefSeq | NP_001306885.1 | 14 | Standard | |
| RefSeq | NP_001306886.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Immune System
- Adaptive Immune System
- Antigen processing: Ubiquitination & Proteasome degradation
- Class I MHC mediated antigen processing & presentation
Biological Process
- protein ubiquitination
- protein autoubiquitination
- positive regulation of canonical Wnt signaling pathway
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- metal ion binding
- ubiquitin protein ligase activity
Cellular Component
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000355387
- Coding exons
- 14
- Length
- 246531
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 125746
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.22 | 234 | 351 | 0.666 | 0.0000214 | 3696 |
| Missense (PolyPhen) | 70 | 134.08 | 0.52207 | 1318 | ||
| Synonymous | 0.0200 | 137 | 137 | 0.998 | 0.00000840 | 1128 |
| Loss of Function | 4.84 | 2 | 31.1 | 0.0643 | 0.00000160 | 339 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00070 | 0.00069 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000027 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that promotes the ubiquitination and proteasomal degradation of SIN3B (By similarity). Independently of its E3 ligase activity, acts as a CTNNB1 stabilizer through USP7-mediated deubiquitination of CTNNB1 promoting Wnt signaling (PubMed:25266658). {ECO:0000250|UniProtKB:Q6PDX6, ECO:0000269|PubMed:25266658}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- LoFtool
- 0.0531
- RVIS EVS
- -0.65
- RVIS percentile EVS
- 16.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.943
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |